Showing results (81-90 of 677) with videos related to
Sort By:
Pageof 68
Pediatric Blood & Cancer|October 20, 2017
Neurofibromatosis type 1 and optic pathway glioma: Molecular interplay and therapeutic insightsSoumen Khatua, David H Gutmann, Roger J PackerBrain Pathology (Zurich, Switzerland)|May 26, 2005
Meningothelial hyperplasia: a detailed clinicopathologic, immunohistochemical and genetic study of 11 casesArie Perry, Eriks A Lusis, David H GutmannAnnual Review of Pathology|January 31, 2017
Dissecting Clinical Heterogeneity in Neurofibromatosis Type 1Courtney L Monroe, Sonika Dahiya, David H GutmannNeuro-Oncology|January 1, 2017
Defining the temporal course of murine neurofibromatosis-1 optic gliomagenesis reveals a therapeutic window to attenuate retinal dysfunctionJoseph A Toonen, Yu Ma, David H GutmannCancer Letters|January 18, 2006
PTEN function in normal and neoplastic growthLionel M L Chow, Suzanne J BakerCold Spring Harbor Perspectives in Biology|September 16, 2024
Glial MalignanciesSuzanne J Baker, Hui Zong, Michelle MonjeOncotarget|January 31, 2012
Capturing the molecular and biological diversity of high-grade astrocytoma in genetically engineered mouse modelsLionel M L Chow, Suzanne J BakerThe Lancet. Neurology|June 21, 2005
Surgery for malignant gliomas: mechanistic reasoning and slippery statisticsPatrick Mitchell, David W Ellison, A David MendelowNeuropathology : Official Journal of the Japanese Society of Neuropathology|December 23, 2017
Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4)Christine Bookhout, Thomas W Bouldin, David W EllisonProceedings of the National Academy of Sciences of the United States of America|December 16, 2004
Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-LRong Rong, Xiaoling Tang, David H Gutmann, et al.Pageof 68